Education
About Us
Working with TipRanks
Follow Us
Actinium Pharmaceuticals (ATNM)
:ATNM
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 81.00K | $ 1.03M | $ 1.14M | $ 0.00 | $ 0.00 |
| Gross Profit | $ 81.00K | $ 331.00K | $ 620.00K | $ -447.00K | $ -420.09K |
| Operating Income | $ -51.92M | $ -34.10M | $ -24.96M | $ -22.39M | $ -22.07M |
| EBITDA | $ -51.13M | $ -33.41M | $ -24.44M | $ -21.77M | $ -21.48M |
| Net Income | $ -48.82M | $ -31.93M | $ -24.58M | $ -22.04M | $ -21.73M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 76.68M | $ 108.91M | $ 77.83M | $ 63.56M | $ 9.25M |
| Total Assets | $ 81.44M | $ 114.19M | $ 80.39M | $ 66.40M | $ 11.67M |
| Total Debt | $ 2.11M | $ 2.58M | $ 310.00K | $ 738.00K | $ 1.43M |
| Net Debt | $ -74.56M | $ -106.33M | $ -77.52M | $ -62.82M | $ -7.83M |
| Total Liabilities | $ 45.07M | $ 47.71M | $ 6.84M | $ 5.08M | $ 6.03M |
| Stockholders' Equity | $ 36.38M | $ 66.48M | $ 73.55M | $ 61.32M | $ 5.64M |
| Cash Flow | |||||
| Free Cash Flow | $ -47.49M | $ 8.28M | $ -21.00M | $ -21.87M | $ -21.53M |
| Operating Cash Flow | $ -47.34M | $ 8.64M | $ -20.87M | $ -21.62M | $ -21.46M |
| Investing Cash Flow | $ -153.00K | $ -366.00K | $ -133.00K | $ -253.00K | $ -63.89K |
| Financing Cash Flow | $ 14.87M | $ 23.11M | $ 35.22M | $ 76.18M | $ 17.11M |